semaglutide and kidney disease in Diabetic Disease: Integrating Clinical Evidence with Mechanistic Insights Novo Nordisk's Ozempic Gets FDA

Studies from Appetite Journal (2021) found that moderate drinkers on GLP-1 therapy consumed an average of 280 more calories per day than non-drinkers on identical regimens

Centella Asiatica Complex: Gentle hydration meets targeted skin repair with leaf water and active molecules from Centella

In theory, this anabolic signal could directly oppose the catabolic pressure of rapid weight loss, helping to preserve vital muscle tissue

Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF

At Perfect B, we see patients who arrive after self-experimenting based on podcast recommendations

- July 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has received its production run of approximately 20,000 units of its BPC-157 transdermal patch (the "Patch"), the Company's lead product candidate